0001225208-18-000471.txt : 20180103
0001225208-18-000471.hdr.sgml : 20180103
20180103183405
ACCESSION NUMBER: 0001225208-18-000471
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171229
FILED AS OF DATE: 20180103
DATE AS OF CHANGE: 20180103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly John C.
CENTRAL INDEX KEY: 0001430345
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06926
FILM NUMBER: 18507519
MAIL ADDRESS:
STREET 1: 5 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BARD C R INC /NJ/
CENTRAL INDEX KEY: 0000009892
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 221454160
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
BUSINESS PHONE: 9082778000
MAIL ADDRESS:
STREET 1: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
4
1
doc4.xml
X0306
4
2017-12-29
0000009892
BARD C R INC /NJ/
BCR
0001430345
Kelly John C.
C/O C. R. BARD, INC.
730 CENTRAL AVENUE
MURRAY HILL
NJ
07974
1
Common Stock
2017-12-29
4
D
0
6578.5942
0
D
0.0000
D
Option (Right to Buy)
81.6950
2017-12-29
4
D
0
1200.0000
D
2019-12-09
Common Stock
1200.0000
0.0000
D
Phantom Stock Units
2017-12-29
4
A
0
115.7100
331.2400
A
Common Stock
115.7100
5342.5100
D
Phantom Stock Units
2017-12-29
4
D
0
5342.5100
D
Common Stock
5342.5100
0.0000
D
Share Equivalent Units
2017-12-29
4
D
0
5174.0000
D
Common Stock
5174.0000
0.0000
D
This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration").
Award/Grant pursuant to the 2005 Directors' Stock Award Plan, as amended and restated.
These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock.
Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees.
Conversion is 1 for 1.
These units, which are 100% vested, were paid out in cash in accordance with the Merger Agreement.
Includes 8.45 units for dividend credits.
Units granted under the Company's Stock Equivalent Plan for Outside Directors.
These units, which are 100% vested, were assumed by BD at the effective time of the Merger.
Myra McGinley, Attorney-in-Fact
2018-01-03